Information Provided By:
Fly News Breaks for June 21, 2016
IMPV
Jun 21, 2016 | 08:11 EDT
After Elliott Management disclosed a 9.8% stake in Imperva, Oppenheimer analyst Shaul Eyal says he continues to believe that the company's current price does not fully reflect its market opportunity, growth potential, and valuation. The analyst sees Elliott's position in Imperva as a positive step in "tightening the screws" in the business and driving shareholder value. Eyal reiterates an Outperform rating and $60 price target on Imperva's shares.
News For IMPV From the Last 2 Days
There are no results for your query IMPV